Document:

<PAGE>
                                  Exhibit 10.3

                                 BEPARIKO BIOCOM

                                 PROMISSORY NOTE
                                    SERIES I

Date: APRIL 20, 2001                                $100,000

         FOR VALUE RECEIVED, the undersigned, BEPARIKO BIOCOM (the "Borrower"),
incorporated under the laws of Nevada, PROMISES TO PAY to or to the order of
                    (the "Lender"), at such place in _____________ as the Lender
may  designate, the principal amount of $100,000 on or before the date (the "Due
Date") which is the earlier of (i) September 1, 2001, and (ii) the date that the
Borrower completes the acquisition (the "Acquisition") of all the issued shares
of Global Genomics Capital, Inc. ("GGC"), plus interest on such principal at the
rate, calculated in the manner and payable at the times specified in this Note.

         The principal amount from time to time unpaid and outstanding hereunder
shall bear interest, both before and after default and before and after
judgment, at the rate of 10% per annum. Interest at such rate shall accrue daily
and be calculated on the basis of the actual number of days elapsed in a year of
365, and shall be payable on the Due Date. Overdue interest shall bear interest
at the same rate, calculated as aforesaid.

         Upon the written request by the Lender, accompanied by this Note and a
duly executed subscription agreement for shares of common stock of the Borrower,
the Borrower will set-off all, but not less than all, of the principal amount
then owing under this Note against the Lender's obligation to pay the
subscription price pursuant to the subscription agreement. Any such set-off will
be subject to the following terms and conditions:

     a)   the effect of the set-off will be to deem the principal amount then
          outstanding hereunder to be paid in full effective on the date of
          execution of the subscription agreement. Interest will cease to accrue
          on the principal amount so set-off on the date of execution of the
          subscription agreement. Subject to the Borrower complying with
          paragraph (b) below this Note will be deemed to have been paid in full
          and cancelled;

     b)   the set-off of principal against the Lender's obligation to pay the
          subscription price pursuant to the subscription agreement will occur
          at the rate of $2.50 per share of common stock. The Borrower shall
          allot and issue 40,000 shares of common stock of the Borrower. No
          fractional shares will be issued. Certificates for the shares will be
          issued in the name of the Lender and will be delivered to the Lender
          together with a cheque for any accrued and unpaid interest on the
          principal amount so set-off, within ___ days of execution and delivery
          of the subscription agreement; and

     c)   any shares of common stock issued by the Borrower pursuant to a
          subscription agreement delivered together with this Note as aforesaid
          may be subject to hold period requirements imposed by the applicable
          regulatory authorities, which may include a requirement that the
          certificates issued in respect of those securities bear a legend
          confirming the applicable trading restrictions.

                                      -23-
<PAGE>

In the event of any:

     a)   subdivision of the shares of common stock of the Borrower (as such
          common stock is constituted on the date hereof) into a greater number
          of shares of common stock while this Note is outstanding, the number
          of shares which may be acquired upon any subscription paid for by way
          of set-off as contemplated by this Note shall thereafter be deemed to
          be subdivided in like manner and the set-off rate adjusted
          accordingly, and any subscription by the Lender for units contemplated
          by this Note shall be deemed to be a subscription for units including
          shares of common stock of the Borrower as subdivided;

     b)   consolidation of the shares of common stock of the Borrower (as such
          shares are constituted on the date hereof) into a lesser number of
          shares while this Note is outstanding, the number of shares which may
          be acquired upon any subscription paid for by way of set-off as
          contemplated by this Note shall thereafter be deemed to be
          consolidated in like manner and the set-off rate adjusted accordingly,
          and any subscription by the Lender for units contemplated by this Note
          shall be deemed to be a subscription for units including shares of
          common stock of the Borrower as consolidated; and

     c)   capital reorganization or reclassification of the shares of common
          stock of the Borrower or the merger or amalgamation of the Borrower
          with another corporation at any time while this Note is outstanding,
          the Borrower shall thereafter deliver at the time of any subscription
          paid for by way of set-off as contemplated by this Note the number of
          shares the Lender would have been entitled to receive in respect of
          the principal amount so set-off had the set-off occurred before such
          capital reorganization or reclassification of the shares of common
          stock of the Borrower or the merger or amalgamation of the Borrower
          with another corporation.

         In addition, the Borrowers shall grant 50,000 $2.50 Common Stock
Purchase Warrants to purchase a like number of shares of the common stock of
Bepariko BioCom.

         This Note is one of a series of ______similar Promissory Notes
designated as Series I issued by the Borrower for the purpose enabling the
Borrower to advance funds aggregating up to $500,000 to GGC pending completion
of the Financing.

                                      -24-
<PAGE>

         As security for its obligations hereunder the Borrower hereby grants to
the Lender a security interest in the promissory note dated as of _____________,
2001 made between GGC, as borrower, and the Borrower, as lender, in respect of
the advances to be made to GGC. The security interest hereby granted shall rank
pari passu with the security interests granted pursuant to the other Series I
Notes.

IN WITNESS WHEREOF the Borrower has executed this Note this 20th day of April,
2001.

BEPARIKO BIOCOM

Per:
     -----------------------------------
     Authorized Signatory

                                      -25-<PAGE>

                                  Exhibit 10.4
50,000 Common Shares                                                  Void after
Without Par Value                                                April 20, 2004.
                                                                       --

                             SHARE PURCHASE WARRANT

                                 Bepariko Biocom
                                 (the "Company")

This is to certify that, for value received, ______________________________ (the
"Warrant Holder") of __________________________________________________________
has the right to purchase from the Company, upon and subject to the terms and
conditions hereinafter referred to, 50,000 common shares, par value $0.001 per
share (the "Shares") in the capital of the Company. The Shares may be purchased
at a price of $2.50 per Share at any time up to 5:00 p.m. local time in New
York, New York on April 20, 2004. The right to purchase the Shares may be
exercised in whole or in part, by the Warrant Holder only, at the price set
forth above (the "Exercise Price") within the time set forth above by:

     (a)  completing and executing the Subscription Form attached hereto for the
          number of the Shares which the Warrant Holder wishes to purchase, in
          the manner therein indicated;

     (b)  surrendering this Warrant Certificate, together with the complete
          Subscription Form, to StockTrans, Inc., (the "Transfer Agent") at 44
          West Lancaster Avenue, Ardmore, PA 19003; and

     (c)  paying the appropriate Exercise Price, for the number of the Shares of
          the Company subscribed for, either by certified cheque or bank draft
          or money order payable to the Company in Bala Cynwyd, Pennsylvania, or
          such other address as the Company may advise by written notice to the
          address of the Warrant Holder set forth above.

Upon surrender and payment, the Company shall issue to the Warrant Holder or to
such other person or persons as the Warrant Holder may direct, the number of the
Shares subscribed for and will deliver to the Warrant Holder, at the address set
forth on the subscription form, a certificate or certificates evidencing the
number of the Shares subscribed for. If the Warrant Holder subscribes for a
number of Shares which is less than the number of Shares permitted by this
warrant, the Company shall forthwith cause to be delivered to the Warrant Holder
a further Warrant Certificate in respect of the balance of Shares referred to in
this Warrant Certificate not then being subscribed for.

In the event of any subdivision of the common shares of the Company (as such
common shares are constituted on the date hereof) into a greater number of
common shares while this warrant is outstanding, the number of Shares
represented by this warrant shall thereafter be deemed to be subdivided in like
manner and the Exercise Price adjusted accordingly, and any subscription by the
Warrant Holder for Shares hereunder shall be deemed to be a subscription for
common shares of the Company as subdivided.

In the event of any consolidation of the common shares of the Company (as such
common shares are constituted on the date hereof) into a lesser number of common
shares while this warrant is outstanding, the number of Shares represented by
this warrant shall thereafter be deemed to be consolidated in like manner and
the Exercise Price adjusted accordingly, and any subscription by the Warrant
Holder for Shares hereunder shall be deemed to be a subscription for common
shares of the Company as consolidated.

In the event of any capital reorganization or reclassification of the common
shares of the Company or the merger or amalgamation of the Company with another
corporation at any time while this warrant is outstanding, the Company shall
thereafter deliver at the time of purchase of the Shares hereunder the number of
common shares the Warrant Holder would have been entitled to receive in respect
of the number of the Shares so purchased had the right to purchase been
exercised before such capital reorganization or reclassification of the common
shares of the Company or the merger or amalgamation of the Company with another
corporation.

                                      -26-
<PAGE>

If at any time while this, or any replacement, warrant is outstanding:

     (a)  the Company proposes to pay any dividend of any kind upon its common
          shares or make any distribution to the holders of its common shares;

     (b)  the Company proposes to offer for subscription pro rata to the holders
          of its common shares any additional shares of stock of any class or
          other rights;

     (c)  the Company proposes any capital reorganization or classification of
          its common shares or the merger or amalgamation of the Company with
          another corporation; or

     (d)  there is a voluntary or involuntary dissolution, liquidation or
          winding-up of the Company;

The Company shall give to the Warrant Holder at least seven days prior written
notice (the "Notice") of the date on which the books of the Company are to close
or a record is to be taken for such dividend, distribution or subscription
rights, or for determining rights to vote with respect to such reorganization,
reclassification, consolidation, merger, amalgamation, dissolution, liquidation
or winding-up. The Notice shall specify, in the case of any such dividend,
distribution or subscription rights, the date on which holders of common shares
of the Company will be entitled to exchange their common shares for securities
or other property deliverable upon any reorganization, reclassification,
consolidation, merger, amalgamation, sale, dissolution, liquidation or
winding-up, as the case may be. Each Notice shall be delivered by hand,
addressed to the Warrant Holder at the address of the Warrant Holder set forth
above or at such other address as the Warrant Holder may from time to time
specify to the Company in writing.

The holding of this Warrant Certificate or the Warrants represented hereby does
not constitute the Warrant Holder a member of the Company.

Nothing contained herein confers any right upon the Warrant Holder or any other
person to subscribe for or purchase any Shares of the Company at any time
subsequent to 5:00 p.m. local time in New York, New York on April 20, 2004 and
from and after such time, this Warrant and all rights hereunder will be void.

The Warrants represented by this Warrant Certificate are non-transferable. Any
Shares issued pursuant to this Warrant will bear the following legend:

     "THE SECURITIES REPRESENTED BY THIS CERTIFICATE (THE "SECURITIES") HAVE
     BEEN ISSUED IN RELIANCE UPON EXEMPTIONS FROM REGISTRATION UNDER THE
     SECURITIES ACT OF 1933, AS AMENDED (THE "1933 ACT"), AND APPROPRIATE
     EXEMPTIONS FROM REGISTRATION UNDER THE SECURITIES LAWS OF OTHER APPLICABLE
     JURISDICTIONS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD OR
     TRANSFERRED OTHER THAN PURSUANT TO AN EFFECTIVE REGISTRATION UNDER THE 1933
     ACT OR AN EXEMPTION FROM REGISTRATION UNDER THE 1933 ACT AND THE APPLICABLE
     SECURITIES LAWS OF ANY OTHER JURISDICTION. THE ISSUER SHALL BE ENTITLED TO
     REQUIRE AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO IT WITH RESPECT TO
     COMPLIANCE WITH THE 1933 ACT AND APPLICABLE SECURITIES LAWS OF ANY OTHER
     JURISDICTION. TRANSFER OF THE SECURITIES IS PROHIBITED EXCEPT IN ACCORDANCE
     WITH THE PROVISIONS OF REGULATION S (RULE 901 THROUGH 905 AND PRELIMINARY
     NOTES THERETO), PURSUANT TO REGISTRATION UNDER THE 1933 ACT, OR PURSUANT TO
     AN AVAILABLE EXEMPTION FROM REGISTRATION; AND THAT HEDGING TRANSACTIONS
     INVOLVING THOSE SECURITIES MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH
     THE 1933 ACT."

                                      -27-
<PAGE>

Time will be of the essence hereof.

This Warrant Certificate is not valid for any purpose until it has been signed
by the Company.

IN WITNESS WHEREOF, the Company has caused its common seal to be hereto affixed
and this warrant certificate to be signed by one of its directors as of the 20th
day of April, 2001.

Bepariko Biocom

Per:

____________________________________________

                                      -28-
<PAGE>

                                SUBSCRIPTION FORM

                       To: Bepariko Biocom (the "Company")
                         And to: the directors thereof.

Pursuant to the Share Purchase Warrant made the 20th day of April, 2001, the
undersigned hereby subscribes for and agrees to take up ________________________
common shares, par value $0.001 per share (the "Shares") in the capital of the
Company, at a price of $2.50 per Share for the aggregate sum of $_______________
__________________ (the "Subscription Funds"), and encloses herewith a certified
cheque, bank draft or money order payable to the Company in full payment of the
Shares.

The undersigned hereby requests that:

     (a)  the Shares be allotted to the undersigned;

     (b)  the name and address of the undersigned as shown below be entered in
          the registers of members and allotments of the Company;

     (c)  the Shares be issued to the undersigned as fully paid and
          non-assessable common shares of the Company; and

     (d)  a share certificate representing the Shares be issued in the name of
          the undersigned.

Dated this _______ day of ______________, 20__.

                          DIRECTION AS TO REGISTRATION:

(Name and address exactly as you wish them to appear on your share certificate
and in the register of members.)

Full Name(1):
                  --------------------------------------------------------------

Full Address:
                  --------------------------------------------------------------

                  --------------------------------------------------------------

                  --------------------------------------------------------------

                  --------------------------------------------------------------

Signature of Subscriber(1):
                           -----------------------------------------------------

<TABLE>
------------------------------------------------------- -------------------------------------------------------------
<S>                                                              <C>

                                                                 Signature of Subscriber(1) guaranteed by:

    If the name above differs from the name of the
    Subscriber, then please complete the following
                      guarantee:                           -------------------------------------------------------
                                                                        Authorized Signature Number
------------------------------------------------------- -------------------------------------------------------------
</TABLE>

NOTE: The signature to this subscription form must correspond with the name as
recorded on the warrant certificate in every particular without alteration or
enlargement or any change whatever. The signature of the person executing this
power must be guaranteed by a Bank or Trust Company or by a Member of the New
York Stock Exchange.

                                      -29-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00037-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00037-of-00352.parquet"}]]